Art as an alternative asset.
A sober read of what Artprice100, the Sotheby's Mei Moses indices and the Deloitte Art & Finance report actually say — and where signed micro-editions by Andreash fit inside that picture.
What the indices say
Blue-chip contemporary tracked by Artprice100 has historically outperformed the S&P 500 over long horizons, at higher variance. The Mei Moses series shows the same shape: art is an alternative, not a substitute — uncorrelated, illiquid, and dependent on artist trajectory. The Deloitte Art & Finance reports confirm that most collectors under fifty now cite portfolio diversification as a primary motive, alongside cultural value.
Where micro-editions sit
Micro-editions of one to five are the lowest-friction way to enter a serious contemporary market. Gerhard Richter's, Christopher Wool's and Wolfgang Tillmans' earliest small editions all traded, at launch, in the same low-hundreds bracket the Andreash register currently occupies. That does not guarantee appreciation — nothing does — but it is the correct historical bracket to be looking at.
Direct from the artist
Andreash sits pre-representation. Prices are direct-from-artist and the register has not yet been touched by secondary-market inflation. Editions are signed, numbered and shipped worldwide in a rigid tube.
Not financial advice. Art is an illiquid, high-variance asset; acquire pieces you would want to live with regardless of resale.